{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:59:50Z","timestamp":1791820790169,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["RNS065808A"],"award-info":[{"award-number":["RNS065808A"]}]},{"name":"NIH","award":["1S10 RR16798"],"award-info":[{"award-number":["1S10 RR16798"]}]},{"name":"NIH-NIMH","award":["1R03MH098689"],"award-info":[{"award-number":["1R03MH098689"]}]},{"name":"NIH-NINDS","award":["1R01NS079655"],"award-info":[{"award-number":["1R01NS079655"]}]},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Genzyme-Sanofi Corp."},{"name":"Shire HGT"},{"name":"Biomarin Pharm. Corp."},{"name":"Protalix Biotherapeutics"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ymgme.2013.09.011","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T20:03:01Z","timestamp":1379793781000},"page":"172-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease"],"prefix":"10.1016","volume":"111","author":[{"given":"Jameson J.","family":"Ribbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann B.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto R.","family":"Bongarzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo H.B.","family":"Maegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.09.011_bb0255","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2005.04.006","article-title":"The ins and outs of sphingolipid synthesis","volume":"15","author":"Futerman","year":"2005","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0260","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10111","article-title":"A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects","volume":"474","author":"Lee","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature10742","article-title":"Molecular recognition of a single sphingolipid species by a protein's transmembrane domain","volume":"481","author":"Contreras","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0270","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann\u2013Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nm1238","article-title":"Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice","volume":"11","author":"Petrache","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0280","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1017\/S1462399410001602","article-title":"Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases","volume":"12","author":"Fantini","year":"2010","journal-title":"Exp. Rev. Mol. Med."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1022436928925","article-title":"Twenty five years of the \u201cpsychosine hypothesis\u201d: a personal perspective of its history and present status","volume":"23","author":"Suzuki","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0285","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M039610","article-title":"Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture","author":"Hawkins-Salsbury","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.171.3966.73","article-title":"Krabbe's globoid cell leukodystrophy: deficiency of galactocerebrosidase in serum, leukocytes, and fibroblasts","volume":"171","author":"Suzuki","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications","volume":"10","author":"Wenger","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0021-9258(18)69582-1","article-title":"The enzymatic synthesis of psychosine","volume":"235","author":"Cleland","year":"1960","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0006-291X(72)90381-6","article-title":"Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase","volume":"48","author":"Miyatake","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0305","first-page":"255","article-title":"Physiological activity of psychosine","volume":"34","author":"Taketomi","year":"1964","journal-title":"Jpn. J. Exp. Med."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0310","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.6719111","article-title":"Progressive accumulation of toxic metabolite in a genetic leukodystrophy","volume":"224","author":"Igisu","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.01.017","article-title":"Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease","volume":"419","author":"Chuang","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-8993(80)90159-6","article-title":"The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease)","volume":"202","author":"Kobayashi","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(97)06527-3","article-title":"Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies","volume":"262","author":"Chatelut","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-8981(05)80003-8","article-title":"Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-d-galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease","volume":"205","author":"Wiederschain","year":"1992","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ab.2011.04.032","article-title":"Immunodetection of caspase-3 by Western blot using glutaraldehyde","volume":"415","author":"Nestal de Moraes","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0320","first-page":"1279","article-title":"Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography\u2013tandem mass spectrometry","volume":"37","author":"Kaneko","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0325","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jchromb.2009.02.037","article-title":"High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry","volume":"877","author":"Stahlman","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0330","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jnr.22564","article-title":"Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease","volume":"89","author":"White","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0120","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.1996.66031118.x","article-title":"Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the Twitcher mouse, a model of Krabbe's disease","volume":"66","author":"Sakai","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0335","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.D005322","article-title":"A rapid and quantitative LC\u2013MS\/MS method to profile sphingolipids","volume":"51","author":"Scherer","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-2275(20)39839-4","article-title":"Krabbe disease: a galactosylsphingosine (psychosine) lipidosis","volume":"21","author":"Svennerholm","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0135","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s11064-010-0348-3","article-title":"Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples","volume":"36","author":"Li","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0340","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3","volume":"14","author":"Schueler","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4161\/auto.5227","article-title":"Lysosomal storage diseases as disorders of autophagy","volume":"4","author":"Settembre","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0160","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1021\/ac049643d","article-title":"Use of 1.5-microm porous ethyl-bridged hybrid particles as a stationary-phase support for reversed-phase ultrahigh-pressure liquid chromatography","volume":"76","author":"Mellors","year":"2004","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0165","series-title":"Assay Guidance Manual","author":"Sittampalam","year":"2004"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-4547(20000415)60:2<231::AID-JNR12>3.0.CO;2-E","article-title":"l-Cycloserine slows the clinical and pathological course in mice with globoid cell leukodystrophy (Twitcher mice)","volume":"60","author":"LeVine","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/08830738030180090201","article-title":"Globoid cell leukodystrophy (Krabbe's disease): update","volume":"18","author":"Suzuki","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.4.070802.110415","article-title":"Enzyme therapy for lysosomal storage disease: principles, practice, and prospects","volume":"4","author":"Grabowski","year":"2003","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/00006450-200201000-00009","article-title":"Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy","volume":"51","author":"Biswas","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0365","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pediatrneurol.2008.11.010","article-title":"Newborn screening for Krabbe disease: the New York State model","volume":"40","author":"Duffner","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1027324230923","article-title":"Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression","volume":"32","author":"Buntinx","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1027339222720","article-title":"Temperature-dependent regulation of PLP\/DM20 and CNP gene expression in two conditionally-immortalized jimpy oligodendrocyte cell lines","volume":"22","author":"Bongarzone","year":"1997","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0380","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.1993.tb03188.x","article-title":"Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus","volume":"60","author":"Verity","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0385","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/BF01179985","article-title":"Isolation and characterization of defective jimpy oligodendrocytes in culture","volume":"24","author":"Feutz","year":"1995","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0390","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.1058","article-title":"An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway","volume":"34","author":"Feutz","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2013.09.011_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1471-4159.2009.06311.x","article-title":"Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes","volume":"111","author":"Baarine","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0235","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jnr.10247","article-title":"Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher)","volume":"68","author":"Shen","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0240","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1016\/S0021-9258(18)67315-6","article-title":"Cultured oligodendrocytes A role for cell\u2013substratum interaction in phenotypic expression","volume":"261","author":"Yim","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0395","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2003.12.126","article-title":"Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation","volume":"358","author":"Zaka","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0250","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1194\/jlr.M600084-JLR200","article-title":"Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death","volume":"47","author":"Giri","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0400","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1101\/gad.1658508","article-title":"Mitochondrial dynamics and apoptosis","volume":"22","author":"Suen","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0405","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.09.011_bb0410","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.jprot.2012.02.014","article-title":"An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue","volume":"75","author":"Lam","year":"2012","journal-title":"J. Proteome"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T11:23:51Z","timestamp":1646565831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1096719213003235"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.09.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}